.Ascendis Pharma has become a prospective danger to BioMarin's Voxzogo, disclosing phase 3 developme...
.Though Alkeus Pharmaceuticals' oral eye health condition possession failed to substantially lower g...
.With a triad of biotechs striking the Nasdaq on Friday, it was very easy to skip a smaller-scale so...
.Invulnerable gate preventions are the superheroes of cancer cells treatment. Medicines like Bristol...
.Welcome to today's Chutes & Ladders, our roundup of notable management hirings, shootings as wel...
.Regeneron is back along with long-term consequence for its own LAG-3 inhibitor and PD-1 prevention ...
.AstraZeneca has actually shared a very early consider the efficiency of its own in-house antibody-d...
.After revealing a stage 3 launch based on beneficial midstage outcomes, iTeos as well as GSK are ac...
.The FDA ought to be a lot more open as well as collective to let loose a rise in approvals of rare ...
.It's an extraordinarily active Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bi...